These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 9298962

  • 21. Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.
    Farid RS, Bianchi ME, Falciola L, Engelsberg BN, Billings PC.
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):532-9. PubMed ID: 8975778
    [Abstract] [Full Text] [Related]

  • 22. Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
    Zamble DB, Mu D, Reardon JT, Sancar A, Lippard SJ.
    Biochemistry; 1996 Aug 06; 35(31):10004-13. PubMed ID: 8756462
    [Abstract] [Full Text] [Related]

  • 23. Intercalating residues determine the mode of HMG1 domains A and B binding to cisplatin-modified DNA.
    He Q, Ohndorf UM, Lippard SJ.
    Biochemistry; 2000 Nov 28; 39(47):14426-35. PubMed ID: 11087395
    [Abstract] [Full Text] [Related]

  • 24. Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro.
    Patrick SM, Turchi JJ.
    Biochemistry; 1998 Jun 16; 37(24):8808-15. PubMed ID: 9628743
    [Abstract] [Full Text] [Related]

  • 25. Electrospray ionization-mass spectrometry study of the interaction of cisplatin-adducted oligonucleotides with human XPA minimal binding domain protein.
    Xu N, Pasa-Tolić L, Smith RD, Ni S, Thrall BD.
    Anal Biochem; 1999 Jul 15; 272(1):26-33. PubMed ID: 10405289
    [Abstract] [Full Text] [Related]

  • 26. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
    Kaspárková J, Nováková O, Vrána O, Farrell N, Brabec V.
    Biochemistry; 1999 Aug 24; 38(34):10997-1005. PubMed ID: 10460154
    [Abstract] [Full Text] [Related]

  • 27. Stopped-flow fluorescence studies of HMG-domain protein binding to cisplatin-modified DNA.
    Jamieson ER, Lippard SJ.
    Biochemistry; 2000 Jul 25; 39(29):8426-38. PubMed ID: 10913248
    [Abstract] [Full Text] [Related]

  • 28. Modulation of MutS ATP-dependent functional activities by DNA containing a cisplatin compound lesion (base damage and mismatch).
    Sedletska Y, Fourrier L, Malinge JM.
    J Mol Biol; 2007 May 25; 369(1):27-40. PubMed ID: 17400248
    [Abstract] [Full Text] [Related]

  • 29. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
    Zhai X, Beckmann H, Jantzen HM, Essigmann JM.
    Biochemistry; 1998 Nov 17; 37(46):16307-15. PubMed ID: 9819223
    [Abstract] [Full Text] [Related]

  • 30. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.
    Hofr C, Farrell N, Brabec V.
    Nucleic Acids Res; 2001 May 15; 29(10):2034-40. PubMed ID: 11353072
    [Abstract] [Full Text] [Related]

  • 31. The effect of the acidic tail on the DNA-binding properties of the HMG1,2 class of proteins: insights from tail switching and tail removal.
    Lee KB, Thomas JO.
    J Mol Biol; 2000 Nov 24; 304(2):135-49. PubMed ID: 11080451
    [Abstract] [Full Text] [Related]

  • 32. Structure-specific binding of the two tandem HMG boxes of HMG1 to four-way junction DNA is mediated by the A domain.
    Webb M, Thomas JO.
    J Mol Biol; 1999 Nov 26; 294(2):373-87. PubMed ID: 10610765
    [Abstract] [Full Text] [Related]

  • 33. Single d(GpG)/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization.
    Suo Z, Lippard SJ, Johnson KA.
    Biochemistry; 1999 Jan 12; 38(2):715-26. PubMed ID: 9888812
    [Abstract] [Full Text] [Related]

  • 34. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
    Kaspárková J, Brabec V.
    Biochemistry; 1995 Sep 26; 34(38):12379-87. PubMed ID: 7547982
    [Abstract] [Full Text] [Related]

  • 35. DNA oligonucleotide duplexes containing intramolecular platinated cross-links: energetics, hydration, sequence, and ionic effects.
    Kankia BI, Soto AM, Burns N, Shikiya R, Tung CS, Marky LA.
    Biopolymers; 2002 Nov 05; 65(3):218-27. PubMed ID: 12228927
    [Abstract] [Full Text] [Related]

  • 36. Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts.
    Whitehead JP, Lippard SJ.
    Met Ions Biol Syst; 1996 Nov 05; 32():687-726. PubMed ID: 8640535
    [No Abstract] [Full Text] [Related]

  • 37. The recognition of distorted DNA structures by HMG-D: a footprinting and molecular modelling study.
    Payet D, Hillisch A, Lowe N, Diekmann S, Travers A.
    J Mol Biol; 1999 Nov 19; 294(1):79-91. PubMed ID: 10556030
    [Abstract] [Full Text] [Related]

  • 38. Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins.
    Mikata Y, He Q, Lippard SJ.
    Biochemistry; 2001 Jun 26; 40(25):7533-41. PubMed ID: 11412107
    [Abstract] [Full Text] [Related]

  • 39. Basic and acidic regions flanking the HMG domain of maize HMGa modulate the interactions with DNA and the self-association of the protein.
    Ritt C, Grimm R, Fernandez S, Alonso JC, Grasser KD.
    Biochemistry; 1998 Feb 24; 37(8):2673-81. PubMed ID: 9485418
    [Abstract] [Full Text] [Related]

  • 40. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.
    Huang JC, Zamble DB, Reardon JT, Lippard SJ, Sancar A.
    Proc Natl Acad Sci U S A; 1994 Oct 25; 91(22):10394-8. PubMed ID: 7937961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.